Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
HALOETTE SEARCHLIGHT PHARMA INC Anticipated shortage 11.7MG 2.7MG Updated Report 2025-11-06 266226
VANCOCIN SEARCHLIGHT PHARMA INC Resolved 125MG Updated Report 2025-11-06 263233
VANCOCIN SEARCHLIGHT PHARMA INC Resolved 250MG Updated Report 2025-11-06 263238
APO-ESOMEPRAZOLE APOTEX INC Actual shortage 20MG Updated Report 2025-11-06 271260
APO-SITAGLIPTIN MALATE APOTEX INC Actual shortage 50MG Updated Report 2025-11-06 271257
APO-TOPIRAMATE APOTEX INC Actual shortage 100MG New Report 2025-11-06 271254
APO-DULOXETINE APOTEX INC Actual shortage 60MG Updated Report 2025-11-06 271251
APO-LEVOTHYROXINE APOTEX INC Actual shortage 50MCG Updated Report 2025-11-06 262425
APO-LEVOTHYROXINE APOTEX INC Actual shortage 112MCG Updated Report 2025-11-06 260693
APO-DAPAGLIFLOZIN APOTEX INC Actual shortage 10MG Updated Report 2025-11-06 267020

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
ATIVAN PFIZER CANADA ULC Discontinued 2MG Updated Report 2025-11-03 269840
ATIVAN PFIZER CANADA ULC Discontinued 1MG Updated Report 2025-11-03 269837
ATIVAN PFIZER CANADA ULC Discontinued 0.5MG Updated Report 2025-11-03 269831
ATIVAN PFIZER CANADA ULC Discontinued 2MG Updated Report 2025-11-03 269826
CEENU BRISTOL-MYERS SQUIBB CANADA To be discontinued 10MG Updated Report 2025-10-31 137687
CEENU BRISTOL-MYERS SQUIBB CANADA To be discontinued 40MG Updated Report 2025-10-31 137690
IMITREX DF - TAB 50MG GLAXOSMITHKLINE INC Discontinued 50MG New Report 2025-10-30 270582
CLINDOXYL GEL GLAXOSMITHKLINE INC To be discontinued 5% 1% New Report 2025-10-29 270515
KIVEXA VIIV HEALTHCARE ULC To be discontinued 300MG 600MG Updated Report 2025-10-29 238375
PANTOPRAZOLE T SANIS HEALTH INC Discontinued 40MG Updated Report 2025-10-28 270365